This report, The changing nature of diagnosis, sets out the implications for practitioners and patients of the technological revolution in diagnosis. The report includes three priorities for action ...

Heather is a biomedical policy analyst who first developed an interest in policy when exploring the evidence base for secondary findings and associated risk estimates in individuals with and without a ...

Antimicrobial resistance (AMR) is one of the greatest challenges facing health systems, causing an estimated 4.71 million deaths globally in 2021. It has been ten years since the World Health ...

It is no secret that the AI regulatory landscape has experienced monumental shifts in the last six months. Rhetoric that views regulation as a barrier to AI innovation and the cross-sectoral ...

In this blog, I will delve into some of the growing acceptance in healthcare to innovative approaches in various countries, and how a database will facilitate analysis and interpretation for all. The ...

The virtual launch this month of the Africa Pathogen Genomics Initiative (Africa PGI) marked a ground-breaking initiative to tackle infectious disease in Africa. Led by the African Union Commission ...

The Wellcome Trust recently announced that they are funding a research programme to investigate synthetic human genomes, and Laura Blackburn had the opportunity to comment for radio coverage of the ...

We are getting closer to a world where the debilitating pain and complications of sickle cell disease are a thing of the past. For the 17,500 people in the UK living with this genetic condition, this ...

With the current pandemic of bird flu – avian influenza – there is a growing concern around diseases spilling over from animals to humans. The COVID-19 pandemic highlighted the devastating impact such ...

Across these two policy briefings, we outline what functional genomics is, the approaches used in this field and explore the potential impact of functional genomics on clinical medicine.

A new type of medicine that uses an approach called ‘gene silencing’ has been approved for use in the NHS in England.